What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli

Virulence

Volumn 3, Issue 3, 2012, Pages 231-233

  Hadjifrangiskou, Maria ^a   Hultgren, Scott J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADHESIN; BACTERIAL PROTEIN; CYCLIC AMP; MEMBRANE PROTEIN; PROTEIN MPPA; SALICYLIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FIM; TYPE 1 PILI PROTEIN; UNCLASSIFIED DRUG; YERSINIABACTIN; ANTIINFECTIVE AGENT; DNA BINDING PROTEIN; ESCHERICHIA COLI PROTEIN; MARA PROTEIN, E COLI; SALICYLIC ACID DERIVATIVE;

BACTERIAL STRAIN; BIOFILM; EDITORIAL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; INTRACELLULAR BACTERIUM; MEDICAL DEVICE; MICROBIAL COMMUNITY; NONHUMAN; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UROPATHOGENIC ESCHERICHIA COLI; BIOSYNTHESIS; FIMBRIA; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NOTE; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BIOFILMS; DNA-BINDING PROTEINS; ESCHERICHIA COLI PROTEINS; FIMBRIAE, BACTERIAL; SALICYLATES; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84862860821     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.19763     Document Type: Editorial

References (39)

1. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 8:881-90; PMID:12194761; http://dx.doi.org/10.3201/eid0809.020063
2. Beloin C, Roux A, Ghigo JM. Escherichia coli biofilms. Curr Top Microbiol Immunol 2008; 322:249-89; PMID:18453280; http://dx.doi.org/10.1007/978-3-540-75418-3_12
3. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilmlike pods in urinary tract infections. Science 2003; 301:105-7; PMID:12843396; http://dx.doi.org/10. 1126/science.1084550
4. Hung CS, Bouckaert J, Hung D, Pinkner J, Widberg C, DeFusco A, et al. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol 2002; 44:903-15; PMID: 12010488; http://dx.doi.org/10.1046/j.1365-2958. 2002.02915.x
5. Pratt LA, Kolter R. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 1998; 30:285-93; PMID:9791174; http://dx.doi.org/10.1046/j.1365-2958.1998.01061.x
6. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 2000; 19:2803-12; PMID:10856226; http://dx.doi.org/10.1093/emboj/ 19.12.2803
7. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 1998; 282:1494-7; PMID: 9822381; http://dx.doi.org/10.1126/science.282.5393. 1494
8. Waksman G, Hultgren SJ. Structural biology of the chaperone-usher pathway of pilus biogenesis. Nat Rev Microbiol 2009; 7:765-74; PMID:19820722; http:// dx.doi.org/10.1038/nrmicro2220
9. Welch RA, Burland V, Plunkett G, 3rd, Redford P, Roesch P, Rasko D, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 2002; 99:17020-4; PMID:12471157; http://dx.doi. org/10.1073/pnas.252529799
10. Chen SL, Hung CS, Pinkner JS, Walker JN, Cusumano CK, Li Z, et al. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci U S A 2009; 106:22439-44; PMID:20018753; http:// dx.doi.org/10.1073/pnas.0902179106
11. Chen SL, Hung CS, Xu J, Reigstad CS, Magrini V, Sabo A, et al. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci U S A 2006; 103:5977-82; PMID:16585510; http:// dx.doi.org/10.1073/pnas.0600938103
12. Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 2011; 80:1516-29; PMID:21542868; http://dx.doi.org/10.1111/j.1365-2958.2011.07660.x
13. Spurbeck RR, Stapleton AE, Johnson JR, Walk ST, Hooton TM, Mobley HL. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 2011; 79:4753-63; PMID:21911462; http://dx.doi. org/10.1128/IAI.05621-11
14. Nilsson LM, Yakovenko O, Tchesnokova V, Thomas WE, Schembri MA, Vogel V, et al. The cysteine bond in the Escherichia coli FimH adhesin is critical for adhesion under flow conditions. Mol Microbiol 2007; 65:1158-69; PMID:17697252; http://dx.doi.org/10. 1111/j.1365-2958.2007.05858.x
15. Thankavel K, Madison B, Ikeda T, Malaviya R, Shah AH, Arumugam PM, et al. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domainspecific antibody to confer protection against experimental urinary tract infection. J Clin Invest 1997; 100:1123-36; PMID:9276729; http://dx.doi.org/10. 1172/JCI119623
16. Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci 2001; 114:4095-103; PMID:11739641
17. Thumbikat P, Berry RE, Zhou G, Billips BK, Yaggie RE, Zaichuk T, et al. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog 2009; 5:e1000415; PMID:19412341; http:// dx.doi.org/10.1371/journal.ppat.1000415
18. Bouckaert J, Berglund J, Schembri M, De Genst E, Cools L, Wuhrer M, et al. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 2005; 55:441-55; PMID:15659162; http://dx.doi.org/10. 1111/j.1365-2958.2004.04415.x
19. Wellens A, Garofalo C, Nguyen H, Van Gerven N, Slättegård R, Hernalsteens JP, et al. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One 2008; 3:e2040; PMID:18446213; http://dx.doi.org/10.1371/journal.pone.0002040
20. Eto DS, Jones TA, Sundsbak JL, Mulvey MA. Integrinmediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 2007; 3: e100; PMID:17630833; http://dx.doi.org/10.1371/ journal.ppat.0030100
21. Wright KJ, Seed PC, Hultgren SJ. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 2007; 9:2230-41; PMID:17490405; http://dx.doi.org/ 10.1111/j.1462-5822.2007.00952.x
22. Abraham JM, Freitag CS, Clements JR, Eisenstein BI. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A 1985; 82:5724-7; PMID:2863818; http:// dx.doi.org/10.1073/pnas.82.17.5724
23. Gally DL, Leathart J, Blomfield IC. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol Microbiol 1996; 21:725-38; PMID:8878036; http://dx. doi.org/10.1046/j.1365-2958.1996.311388.x
24. Hannan TJ, Mysorekar IU, Chen SL, Walker JN, Jones JM, Pinkner JS, et al. LeuX tRNA-dependent and-independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol Microbiol 2008; 67:116-28; PMID:18036139
25. Klemm P. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J 1986; 5:1389-93; PMID: 2874022
26. van der Woude MW, Braaten BA, Low DA. Evidence for global regulatory control of pilus expression in Escherichia coli by Lrp and DNA methylation: model building based on analysis of pap. Mol Microbiol 1992; 6:2429-35; PMID:1357527; http://dx.doi.org/10. 1111/j.1365-2958.1992.tb01418.x
27. Kawula TH, Orndorff PE. Rapid site-specific DNA inversion in Escherichia coli mutants lacking the histonelike protein H-NS. J Bacteriol 1991; 173: 4116-23; PMID:1648076
28. Müller CM, Aberg A, Straseviçiene J, Emody L, Uhlin BE, Balsalobre C. Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRP-cAMP. PLoS Pathog 2009; 5:e1000303; PMID:19229313; http://dx.doi. org/10.1371/journal.ppat.1000303
29. Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol Microbiol 2009; 73:1020-31; PMID:19703104; http://dx.doi.org/10.1111/j.1365-2958.2009.06826.x
30. Vila J, Soto SM. Salicylate increases the expression of marA and reduces in vitro biofilm formation in uropathogenic Escherichia coli by decreasing type 1 fimbriae expression. Virulence 2012. In press.
31. Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, et al. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog 2009; 5:e1000305; PMID:19229321; http:// dx.doi.org/10.1371/journal.ppat.1000305
32. Rakin A, Noelting C, Schubert S, Heesemann J. Common and specific characteristics of the highpathogenicity island of Yersinia enterocolitica. Infect Immun 1999; 67:5265-74; PMID:10496905
33. Schubert S, Rakin A, Fischer D, Sorsa J, Heesemann J. Characterization of the integration site of Yersinia high-pathogenicity island in Escherichia coli. FEMS Microbiol Lett 1999; 179:409-14; PMID:10518744; http://dx.doi.org/10.1111/j.1574-6968.1999.tb08756.x
34. Price CT, Lee IR, Gustafson JE. The effects of salicylate on bacteria. Int J Biochem Cell Biol 2000; 32:1029-43; PMID:11091136; http://dx.doi.org/10. 1016/S1357-2725(00)00042-X
35. Cohen SP, Levy SB, Foulds J, Rosner JL. Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J Bacteriol 1993; 175:7856-62; PMID: 7504664
36. Reigstad CS, Hultgren SJ, Gordon JI. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem 2007; 282: 21259-67; PMID:17504765; http://dx.doi.org/10. 1074/jbc.M611502200
37. Wang X, Kim Y, Hong SH, Ma Q, Brown BL, Pu M, et al. Antitoxin MqsA helps mediate the bacterial general stress response. Nat Chem Biol 2011; 7:359-66; PMID:21516113; http://dx.doi.org/10.1038/ nchembio.560
38. Li H, Park JT. The periplasmic murein peptidebinding protein MppA is a negative regulator of multiple antibiotic resistance in Escherichia coli. J Bacteriol 1999; 181:4842-7; PMID:10438753
39. McMurry LM, Levy SB. The periplasmic protein MppA is not involved in regulation of marA in Escherichia coli. Antimicrob Agents Chemother 2011; 55:4939; PMID:21788455; http://dx.doi.org/ 10.1128/AAC.05030-11